Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 96,338 shares at $5.45 ($525K) on 2017-01-26, disclosed to the SEC on 2017-01-30.
Open-market purchase of $525k MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.44 | 19,330 | $105K | 20.0% |
| 2 | $5.44 | 19,330 | $105K | 20.0% |
| 3 | $5.45 | 28,839 | $157K | 30.0% |
| 4 | $5.45 | 28,839 | $157K | 30.0% |
| Total | $5.45 avg | 96,338 | $525K | 100% |
| Filing → |
| MRTX | SELL | 2020-06-16 | $58.2M | — | Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |